Warts (non-genital).

L Nai-Ming - BMJ clinical evidence, 2007 - europepmc.org
Warts are caused by the human papilloma virus, of which there are over 100 types, which
probably infects the skin via areas of minimal trauma. Risk factors include use of communal …

A case of severe eczema following use of imiquimod 5% cream

CL Taylor, M Maslen, M Kapembwa - Sexually transmitted infections, 2006 - sti.bmj.com
Imiquimod 5% cream, an immune response modifier licensed for treatment of external ano-
genital warts and superficial basal cell carcinomata, is known to cause local erythema …

Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study

TW Schacker, M Conant, C Thoming… - Antimicrobial agents …, 2002 - Am Soc Microbiol
Present strategies for control of herpes genitalis recurrences require multiple daily doses of
antiviral medication. Imiquimod, an immune response modifier, induces alpha interferon and …

Imiquimod

M Skerlev, I Čulav-Košćak, S Ljubojević Hadžavdić… - 2015 - Springer
Since its first official approval for use in external genital and perianal warts about 16 years
ago, imiquimod has revolutionized not only the therapeutic protocols but also our …

Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children

EI Grussendorf‐Conen, S Jacobs - Pediatric dermatology, 2002 - Wiley Online Library
Long‐lasting cutaneous warts are a therapeutic challenge, especially widespread or
symptomatic recalcitrant warts in children. It can be speculated that natural immunity to these …

The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts.

PC Langley, SK Tyring, MH Smith - The American Journal of …, 1999 - europepmc.org
Objective External genital warts are one of the fastest growing sexually transmitted diseases
in the United States today. Two forms of therapy are available: provider-administered and …

Patient-applied treatment for genital warts: experience from a large postmarketing study

MJ Rosenberg, SC Long, DW Adair… - Journal of …, 1995 - Taylor & Francis
OBJECTIVE To determine the safety, efficacy, and acceptability of self-administered
podofilox for treatment of genital warts when used in everyday circumstances. DESIGN …

Topical imiquimod for the treatment of anogenital warts in an infant

C Skowron, M Raoulx, F Skowron - Annales de dermatologie et de …, 2010 - europepmc.org
Background Treatment of anogenital warts (AW) in children and infants is painful because of
the destructive techniques involved, as a result of which general anaesthesia may be …

The treatment and demographics of warts: an analysis of national trends.

VJ Reeder, CJ Gustafson, SA Davis… - Journal of Drugs in …, 2013 - europepmc.org
Background Verrucae (warts) are a very common dermatologic disease. They can be of
cosmetic concern, cause physical discomfort, and predispose patients to certain …

Imiquimod

KS Jobanputra, AV Rajpal, NG Nagpur - Indian Journal of Dermatology …, 2006 - ijdvl.com
PHARMACOKINETICS [1] Anogenital warts Imiquimod is more efficacious in the treatment of
Topical radiolabeled imiquimod has minimal systemic anogenital warts than …